We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$5.68B
AUM Growth
+$304M
Cap. Flow
+$187M
Cap. Flow %
3.29%
Top 10 Hldgs %
28.5%
Holding
1,247
New
80
Increased
530
Reduced
355
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 11.47%
2 Financials 5.17%
3 Healthcare 4.4%
4 Consumer Discretionary 4.2%
5 Industrials 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXUS icon
426
Vanguard Total International Stock ETF
VXUS
$151B
$782K 0.01%
12,961
-3,613
-22% -$218K
AAA
427
Alternative Access First Priority CLO Bond ETF
AAA
$45M
$775K 0.01%
30,946
+704
+2% +$17.7K
ZTS icon
428
Zoetis
ZTS
$32.7B
$769K 0.01%
4,435
+166
+4% +$27.6K
AEP icon
429
American Electric Power
AEP
$70.4B
$759K 0.01%
8,645
+758
+10% +$66.3K
ACP
430
abrdn Income Credit Strategies Fund
ACP
$631M
$755K 0.01%
111,382
EW icon
431
Edwards Lifesciences
EW
$49.4B
$755K 0.01%
8,171
+261
+3% +$23.1K
AZO icon
432
AutoZone
AZO
$51.3B
$750K 0.01%
253
-2
-0.8% -$5.86K
CGSD icon
433
Capital Group Short Duration Income ETF
CGSD
$2.39B
$748K 0.01%
29,450
HCA icon
434
HCA Healthcare
HCA
$88.4B
$740K 0.01%
2,304
+314
+16% +$102K
IWR icon
435
iShares Russell Mid-Cap ETF
IWR
$55.9B
$739K 0.01%
9,117
-123
-1% -$10K
HSY icon
436
Hershey
HSY
$37.3B
$730K 0.01%
3,970
+112
+3% +$21.7K
MET icon
437
MetLife
MET
$62.4B
$729K 0.01%
10,387
+628
+6% +$44.8K
APD icon
438
Air Products & Chemicals
APD
$65.5B
$728K 0.01%
2,821
-272
-9% -$69K
BSX icon
439
Boston Scientific
BSX
$68.4B
$728K 0.01%
9,449
+1,639
+21% +$120K
AIG icon
440
American International
AIG
$42.5B
$726K 0.01%
9,777
+466
+5% +$35.6K
LQD icon
441
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$726K 0.01%
6,773
-8,247
-55% -$880K
RF icon
442
Regions Financial
RF
$26.4B
$725K 0.01%
36,156
+394
+1% +$7.64K
BP icon
443
BP
BP
$112B
$724K 0.01%
20,059
+3,518
+21% +$132K
SCHE icon
444
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
$722K 0.01%
27,201
-2,053
-7% -$53.5K
BMY icon
445
Bristol-Myers Squibb
BMY
$129B
$719K 0.01%
17,317
+559
+3% +$25K
PAYX icon
446
Paychex
PAYX
$43.4B
$715K 0.01%
6,030
+294
+5% +$35.9K
ARKK icon
447
ARK Innovation ETF
ARKK
$5.59B
$702K 0.01%
15,964
-464
-3% -$20.7K
USB icon
448
US Bancorp
USB
$97.9B
$695K 0.01%
17,513
+2,143
+14% +$87.4K
UBER icon
449
Uber
UBER
$145B
$688K 0.01%
9,468
+1,383
+17% +$96.1K
TDVG icon
450
T. Rowe Price Dividend Growth ETF
TDVG
$1.41B
$684K 0.01%
17,776
-2,773
-13% -$105K

Similar funds

Aptus Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Aptus Capital Advisors held 1,247 positions worth $5.68B, up 5.7% from $5.38B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Aptus Capital Advisors deployed $187M of net new capital in Q2 2024, opening 80 new positions and adding to 530 existing holdings. Its largest new stake was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $18.1M trimmed.

  • Aptus Capital Advisors's largest Q2 2024 buy was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.
  • Aptus Capital Advisors added most to Invesco NASDAQ 100 ETF in Q2 2024, an estimated $27.6M increase.
  • Aptus Capital Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $18.1M.
  • Aptus Capital Advisors fully exited Crocs in Q2 2024, selling an estimated $4.27M.
  • Aptus Capital Advisors's ten largest holdings make up 29% of its $5.68B portfolio in Q2 2024.
  • Aptus Capital Advisors opened 80 new positions and closed 84 in Q2 2024.
  • Aptus Capital Advisors's portfolio value rose 5.7% quarter-over-quarter to $5.68B.

Based on Aptus Capital Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.